Detailseite
Projekt Druckansicht

Hochdurchsatz-Kristallisationseinheit

Fachliche Zuordnung Grundlagen der Biologie und Medizin
Förderung Förderung in 2010
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 193237366
 
Erstellungsjahr 2015

Zusammenfassung der Projektergebnisse

1. The structure biology of photo-reception as well as cell wall and membrane architecture: (i.) Photoreceptors, including phytochromes, cryptochromes, and photolyases that are responsible for signal transduction concerning the plant growth, gene expression, tuning the circadian clock and in case for the photolyases, DNA-repair. (ii.) The structure-activity relationship of mitochondrial membrane voltage-dependent anion channels (VDAC) a key player during the apoptotic process. (iii.) Fungal adhesin superfamily of proteins. 2. Structural elucidation of Fe-S protein biogenesis in eukaryotes: Iron–sulphur (Fe–S) clusters are essential and versatile cofactors of proteins involved in catalysis, electron transport and sensing of ambient conditions. Defects in Fe–S protein biogenesis leads to severe diseases (e.g. cerebral ataxia, anaemia). There are about 20 proteins and protein-protein complexes in this process structurally studied that includes the inner-mitochondrial membrane ABC transporter, Atm1. 3. Structure-based drug design by exploring the structural basis of ligand–protein interaction by X-ray crystallography: Proteins investigated include Factor XIII, HIV-1 protease, tRNA-guanine transglycosylase and thrombin. The crystal structures are the basis for further ligand optimization to obtain highly specific inhibitors with affinities in the nanomolar range. 4. Proteins, which affect the pathogenicity of Shigella sp., the causative agent of bacillary dysentery: OspD1, Spa15 and IpgC are involved in the regulation of the "late" Shigella pathogenicity genes. The project involves understanding the regulation at a structural level, which may, in a longer term, enable us to design small molecules as a means to fight Shigellosis. 5. Understanding enzyme mechanisms for structure-based drug design: Two enzymes are in the current focus of research: (i.) Human aldose reductase; (ii.) Carbonic anhydrases. Both are involved in important physiological and pathological processes including pH homeostasis, bicarbonate metabolism, regulation of intracellular osmotic pressure, biosynthetic reactions (e.g. gluconeogenesis), bone resorption, calcification and tumorgenicity. We are studying sulfonamide/sulfamide inhibitor complexes at high resolution to understand detailed protein–ligand interactions. 6. The structural biology of bacterial macromolecular complexes (e.g. the bacterial flagellum, divisome): The current projects are: (i.) Nucleotide-binding proteins and their accessory factors; (ii.) Components of the flagellar type 3 secretion system (T3SS); (iii.) Factors, which regulate transcription and translation of subunits during assembly of the bacterial flagellum/divisome; (iv.) Alarmone (i.e. (p)ppGpp) producing enzyme complexes; (v.) Flagellum-associated proteins with a role in biofilm formation.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung